https://www.selleck.be/nl-BE/products/pf-07220060-cdk4-6-in-6-cdk4-inhibitor.html
PF-07220060 (CDK4/6-IN-6) | CDK Remmer | CDK Inhibitor | Op voorraad in België | Selleck België
PF-07220060 (CDK4/6-IN-6) is een krachtige CDK4/CDK6-remmer met een Ki van respectievelijk 0,6 nM en 13,9 nM voor CDK4/Cyclin D1 en CDK6/Cyclin D3.
op voorraadpfcdk4remmerinhibitor
https://www.selleckchem.com/products/palbociclib-pd-0332991-cdk4-6-inhibitor.html
Palbociclib (PD-0332991) | CDK4/6 Inhibitor | CAS 571190-30-2 | Selleck Chemicals
Palbociclib (PD 0332991) is a highly specific inhibitor of cyclin-dependent kinase 4 (Cdk4) and Cdk6 with IC50 of 11 nM and 16 nM, respectively. Quality...
palbociclibpdcdk4inhibitorcas
https://www.selleck.au/products/pf-07220060-cdk4-6-in-6-cdk4-inhibitor.html
PF-07220060 (CDK4/6-IN-6) | CDK Inhibitor | AU Stock | Selleck Australia
PF-07220060 (CDK4/6-IN-6) is a potent CDK4/CDK6 inhibitor with a Ki of 0.6 nM and 13.9 nM for CDK4/Cyclin D1 and CDK6/Cyclin D3, respectively.
au stockpfcdk4inhibitoraustralia
https://www.selleck.cn/products/bireociclib-xzp-3287-cdk4-6-in-2-cdk4-6-inhibitor.html
Bireociclib (XZP-3287,CDK4/6-IN-2) | CDK4/6 抑制剂 | 现货供应 | 美国品牌 | 免费采购电话400-668-6834
CDK4/6-IN-2对CDK4和CDK6的抑制活性IC50值分别为2.7 nM和16 nM，相关数据参见专利US20180000819A1中的化合物1。
cdk4
https://oncodaily.com/oncolibrary/breast-oncology/sonia-trial
SONIA Trial Challenges Routine First-Line CDK4/6 Use in Advanced Breast Cancer - OncoDaily
Apr 20, 2026 - First-line vs second-line CDK4/6 inhibitor use in advanced breast cancer showed no OS advantage in SONIA trial, but more toxicity with earlier use.
advanced breast cancerfirst linesoniatrialchallenges